Abstract

BackgroundTo estimate the prognostic value of inflammatory markers in patients with laryngeal squamous cell carcinoma (LSCC).MethodsA total of 361 resected LSCC patients were included. The preoperative and postoperative neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), alkaline phosphatase (ALP) and l actate dehydrogenase (LDH) were assessed. The Kaplan-Meier survival analysis and Cox regression analysis were conducted on overall survival (OS) and progression-free survival (PFS).ResultsBoth Kaplan-Meier analysis and univariate analysis demonstrated significant prognostic value of preoperative and postoperative NLR, PLR and MLR. However, only preoperative ALP was predictive of OS and PFS, and LDH failed to be predictor of OS and PFS. The multivariate analysis showed that preoperative NLR (OS: HR = 1.64, 95%CI: 1.06–2.54, p = 0.026; PFS: HR = 1.52, 95%CI: 1.04–2.23, p = 0.029) and postoperative MLR (OS: HR = 2.02, 95%CI: 1.29–3.14, p = 0.002; PFS: HR = 1.57, 95%CI: 1.05–2.34, p = 0.026) were independently related with survival.ConclusionsThe elevated preoperative NLR, PLR, MLR and ALP were significantly associated with worse survival and cancer progression. The preoperative NLR and postoperative MLR might be independent prognostic markers of OS and PFS in LSCC patients undergoing surgical resection.

Highlights

  • To estimate the prognostic value of inflammatory markers in patients with laryngeal squamous cell carcinoma (LSCC)

  • (OS: hazard ratio (HR) = 2.02, 95%confidence intervals (CI): 1.29–3.14, p = 0.002; progression-free survival (PFS): HR = 1.57, 95%CI: 1.05–2.34, p = 0.026) were independently related with survival

  • The elevated preoperative neutrophilto-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) and alkaline phosphatase (ALP) were significantly associated with worse survival and cancer progression

Read more

Summary

Introduction

To estimate the prognostic value of inflammatory markers in patients with laryngeal squamous cell carcinoma (LSCC). Laryngeal cancer is one of the most common cancers in head and neck region with 26,300 new cases and 14,500 deaths in China in 2015 [1]. The 5-year overall survival rate was approximately 60% in the United States based on SEER Cancer Statistics Review. Laryngeal squamous cell carcinoma (LSCC) accounts for 85–95% of laryngeal cancer [2]. Various treatments are used to cure laryngeal †. Linyan Chen and Xuelei Ma contributed to this work. Innovation Center, No., Guoxue Alley, Chengdu 610041, People’s Republic of China. Full list of author information is available at the end of the article cancer patients, including surgery, radiotherapy and chemotherapy [3].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call